Literature DB >> 25586361

Activation of Wnt/β-catenin/GSK3β signaling during the development of diabetic cardiomyopathy.

Xiao-Hui Xi1, Yan Wang2, Jun Li2, Fu-Wen Wang2, Gui-Hong Tian2, Mao-Shan Yin1, Yan-Ling Mu3, Zhao-Zhong Chong2.   

Abstract

BACKGROUND: As Wnt/β-catenin/glycogen synthase kinase 3β (GSK3β) signaling has been implicated in myocardial injury and diabetic cardiomyopathy (DCM) is a major part of diabetic cardiovascular complications, we therefore investigated the alterations of Wnt/β-catenin/GSK3β signaling during the development of DCM.
METHODS: The rat model of diabetes mellitus (DM) was established using a single intraperitoneal injection of streptozotocin (STZ, 60 mg/kg). The alterations of Wnt/β-catenin/GSK3β signaling were determined 4, 8, and 12 weeks following DM using Western blotting, immunohistochemistry, and quantitative real-time reverse transcriptase polymerase chain reaction. Cardiac pathology changes were evaluated using hematoxylin and eosin, Masson trichromatic, and terminal dUTP nick-end labeling staining.
RESULTS: Histological analyses revealed that DM induced significant myocardial injury and progressive cardiomyocyte apoptosis. The protein and mRNA levels of Wnt2, β-catenin, and c-Myc were progressively increased 4, 8, and 12 weeks following DM. The expression of T-cell factor 4 and phosphorylated of GSK3β on Ser9 were progressively increased. However, the expression of the endogenous Wnt inhibitor Dickkopf-1 was increased after STZ injection and then decreased as DCM developed.
CONCLUSION: Wnt/β-catenin/GSK3β signaling pathway is activated in the development of DCM. Further investigation into the role of Wnt signaling during DCM will functionally find novel therapeutic target for DCM.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic cardiomyopathy; GSK3β; Myocardial injury; Wnt2; β-Catenin

Mesh:

Substances:

Year:  2014        PMID: 25586361     DOI: 10.1016/j.carpath.2014.12.002

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  8 in total

1.  Hydrogen Sulfide Attenuates High Glucose-induced Myocardial Injury in Rat Cardiomyocytes by Suppressing Wnt/beta-catenin Pathway.

Authors:  Min Zhang; Mao Ye
Journal:  Curr Med Sci       Date:  2019-12-16

2.  Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

Authors:  Manisha Gupte; Samvruta Tumuluru; Jennifer Y Sui; Anand Prakash Singh; Prachi Umbarkar; Shan S Parikh; Firdos Ahmad; Qinkun Zhang; Thomas Force; Hind Lal
Journal:  Int J Cardiol       Date:  2018-02-03       Impact factor: 4.164

3.  Swimming training alleviated insulin resistance through Wnt3a/β-catenin signaling in type 2 diabetic rats.

Authors:  Qiang Yang; Wen-Wen Wang; Pu Ma; Zhong-Xuan Ma; Meng Hao; Temitope I Adelusi; Xiao-Xing Yin; Qian Lu
Journal:  Iran J Basic Med Sci       Date:  2017-11       Impact factor: 2.699

4.  Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy.

Authors:  Aurelija Abraityte; Ida G Lunde; Erik T Askevold; Annika E Michelsen; Geir Christensen; Pål Aukrust; Arne Yndestad; Arnt Fiane; Arne Andreassen; Svend Aakhus; Christen P Dahl; Lars Gullestad; Kaspar Broch; Thor Ueland
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

5.  Fufang Xueshuantong Improves Diabetic Cardiomyopathy by Regulating the Wnt/β-Catenin Pathway.

Authors:  Meizhong Peng; Hanying Liu; Qingxuan Ji; Pan Ma; Yiting Niu; Shangqiu Ning; Huihui Sun; Xinxin Pang; Yuqian Yang; Yuting Zhang; Jing Han; Gaimei Hao
Journal:  Int J Endocrinol       Date:  2022-09-19       Impact factor: 2.803

6.  GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway.

Authors:  Ying Ying; Huazhang Zhu; Zhen Liang; Xiaosong Ma; Shiwei Li
Journal:  J Mol Endocrinol       Date:  2015-09-18       Impact factor: 5.098

Review 7.  The Effects of Chinese Medicine on Activation of Wnt/β-Catenin Signal Pathway under High Glucose Condition.

Authors:  Wei Liu; Xiaochun Liang; Dan Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

Review 8.  The complex role of Wnt ligands in type 2 diabetes mellitus and related complications.

Authors:  Xiaobo Nie; Xiaoyun Wei; Han Ma; Lili Fan; Wei-Dong Chen
Journal:  J Cell Mol Med       Date:  2021-05-27       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.